Vertero
Breaking Barriers in Neurodegenerative Disease Treatment
- Headquarters
- Woburn, Massachusetts
- Employees
- 1–10
- Business Model
- B2B
- Website
- vertero.com
About
Vertero Therapeutics is a clinical-stage biotech company pioneering treatments for neurodegenerative diseases by targeting upstream peripheral drivers of brain disease. Their lead candidate VT-5006 is an oral therapeutic designed to modulate a validated gut target that feeds the protein aggregation and inflammation driving Parkinson's disease, and dosed its first patient in a Phase 1b clinical study in 2026. Vertero is headquartered in Woburn, Massachusetts, and is advancing a pipeline of science beyond the brain to delay disease progression and preserve patient quality of life.
Summary
Vertero is a Biotech company based in Woburn, United States.
Tech & App Stack
1 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/vertero"><img src="https://indexed.vc/api/badge/company/vertero" alt="Vertero on Indexed.vc" width="260" height="76" /></a>